vs
合众银行（FSBC）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是合众银行的1.5倍（$69.8M vs $45.1M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 41.3%，领先342.7%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 21.3%）
合众银行是总部设在美国明尼阿波利斯、在特拉华州注册的美国跨国银行机构，截至2025年为美国第五大银行，也是美国中西部规模最大的银行，被金融稳定委员会认定为具有系统重要性的银行。它旗下核心运营实体为美国银行全国协会，以US Bank品牌开展业务，提供银行、投资、抵押等金融服务。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
FSBC vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.5倍
$45.1M
净利率更高
RIGL
高出342.7%
41.3%
两年增速更快
RIGL
近两年复合增速
21.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $45.1M | $69.8M |
| 净利润 | $18.6M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | — | 33.2% |
| 净利率 | 41.3% | 384.0% |
| 营收同比 | — | 21.2% |
| 净利润同比 | 42.0% | 1769.2% |
| 每股收益（稀释后） | $0.87 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FSBCRIGL
| Q1 26 | $45.1M | — | ||
| Q4 25 | $43.5M | $69.8M | ||
| Q3 25 | $41.3M | $69.5M | ||
| Q2 25 | $38.3M | $101.7M | ||
| Q1 25 | $35.3M | $53.3M | ||
| Q4 24 | $35.2M | $57.6M | ||
| Q3 24 | $31.8M | $55.3M | ||
| Q2 24 | $30.7M | $36.8M |
净利润FSBCRIGL
| Q1 26 | $18.6M | — | ||
| Q4 25 | $17.6M | $268.1M | ||
| Q3 25 | $16.3M | $27.9M | ||
| Q2 25 | $14.5M | $59.6M | ||
| Q1 25 | $13.1M | $11.4M | ||
| Q4 24 | $13.3M | $14.3M | ||
| Q3 24 | $10.9M | $12.4M | ||
| Q2 24 | $10.8M | $-1.0M |
毛利率FSBCRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% |
营业利润率FSBCRIGL
| Q1 26 | — | — | ||
| Q4 25 | 52.9% | 33.2% | ||
| Q3 25 | 53.8% | 40.9% | ||
| Q2 25 | 52.4% | 60.1% | ||
| Q1 25 | 52.0% | 23.9% | ||
| Q4 24 | 55.1% | 28.9% | ||
| Q3 24 | 48.0% | 25.4% | ||
| Q2 24 | 49.4% | 1.2% |
净利率FSBCRIGL
| Q1 26 | 41.3% | — | ||
| Q4 25 | 40.6% | 384.0% | ||
| Q3 25 | 39.6% | 40.2% | ||
| Q2 25 | 37.9% | 58.6% | ||
| Q1 25 | 37.1% | 21.5% | ||
| Q4 24 | 37.9% | 24.9% | ||
| Q3 24 | 34.4% | 22.5% | ||
| Q2 24 | 35.2% | -2.8% |
每股收益（稀释后）FSBCRIGL
| Q1 26 | $0.87 | — | ||
| Q4 25 | $0.83 | $14.11 | ||
| Q3 25 | $0.77 | $1.46 | ||
| Q2 25 | $0.68 | $3.28 | ||
| Q1 25 | $0.62 | $0.63 | ||
| Q4 24 | $0.61 | $0.82 | ||
| Q3 24 | $0.52 | $0.70 | ||
| Q2 24 | $0.51 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $644.4M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $458.5M | $391.5M |
| 总资产 | $5.0B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资FSBCRIGL
| Q1 26 | $644.4M | — | ||
| Q4 25 | — | $155.0M | ||
| Q3 25 | — | $137.1M | ||
| Q2 25 | — | $108.4M | ||
| Q1 25 | — | $77.1M | ||
| Q4 24 | — | $77.3M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | — | $49.1M |
总债务FSBCRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M |
股东权益FSBCRIGL
| Q1 26 | $458.5M | — | ||
| Q4 25 | $445.8M | $391.5M | ||
| Q3 25 | $431.3M | $117.6M | ||
| Q2 25 | $416.7M | $81.9M | ||
| Q1 25 | $406.5M | $18.6M | ||
| Q4 24 | $396.6M | $3.3M | ||
| Q3 24 | $389.9M | $-14.6M | ||
| Q2 24 | $380.5M | $-29.9M |
总资产FSBCRIGL
| Q1 26 | $5.0B | — | ||
| Q4 25 | $4.8B | $513.6M | ||
| Q3 25 | $4.6B | $242.5M | ||
| Q2 25 | $4.4B | $206.7M | ||
| Q1 25 | $4.2B | $176.0M | ||
| Q4 24 | $4.1B | $164.0M | ||
| Q3 24 | $3.9B | $139.4M | ||
| Q2 24 | $3.6B | $128.4M |
负债/权益比FSBCRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流FSBCRIGL
| Q1 26 | — | — | ||
| Q4 25 | $72.6M | $22.0M | ||
| Q3 25 | $18.8M | $24.0M | ||
| Q2 25 | $17.8M | $30.5M | ||
| Q1 25 | $15.5M | $-893.0K | ||
| Q4 24 | $51.8M | $14.5M | ||
| Q3 24 | $17.5M | $21.7M | ||
| Q2 24 | $16.0M | $302.0K |
自由现金流FSBCRIGL
| Q1 26 | — | — | ||
| Q4 25 | $71.4M | — | ||
| Q3 25 | $18.6M | — | ||
| Q2 25 | $17.5M | — | ||
| Q1 25 | $15.4M | — | ||
| Q4 24 | $51.2M | — | ||
| Q3 24 | $17.3M | — | ||
| Q2 24 | $15.8M | — |
自由现金流率FSBCRIGL
| Q1 26 | — | — | ||
| Q4 25 | 164.3% | — | ||
| Q3 25 | 45.0% | — | ||
| Q2 25 | 45.8% | — | ||
| Q1 25 | 43.5% | — | ||
| Q4 24 | 145.5% | — | ||
| Q3 24 | 54.5% | — | ||
| Q2 24 | 51.6% | — |
资本支出强度FSBCRIGL
| Q1 26 | — | — | ||
| Q4 25 | 2.8% | — | ||
| Q3 25 | 0.5% | — | ||
| Q2 25 | 0.6% | — | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | 1.8% | — | ||
| Q3 24 | 0.7% | — | ||
| Q2 24 | 0.7% | — |
现金转化率FSBCRIGL
| Q1 26 | — | — | ||
| Q4 25 | 4.12× | 0.08× | ||
| Q3 25 | 1.15× | 0.86× | ||
| Q2 25 | 1.23× | 0.51× | ||
| Q1 25 | 1.18× | -0.08× | ||
| Q4 24 | 3.89× | 1.01× | ||
| Q3 24 | 1.60× | 1.75× | ||
| Q2 24 | 1.49× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FSBC
| Net Interest Income | $43.5M | 96% |
| Noninterest Income | $1.6M | 4% |
RIGL
暂无分部数据
